BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld
Home
» In the clinic for Oct. 5, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
In the clinic for Oct. 5, 2021
Oct. 5, 2021
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx, Annovis, Bayer, Biogen, Brii, CTI, Emphycorp, Enanta, Erytech, Galapagos, Horizon, Immunitybio, Incyte, Kintor, Janssen, Kaleido, Lutris, Lyra, Mannkind, Mereo, Merck, Opthea, PDS, PEP-Therapy, Pharmaxis, Redhill, Regenxbio, Roche, SAB, Sage, Sarepta, Som, Surface Oncology, Telix, Ultragenyx, Unity, Vedanta, Vyne, X4, Xenon, Zymeworks.
BioWorld
Briefs
Clinical
In the clinic
Coronavirus